Skip to main content
logo
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.2986
+0.0139 (4.88%)
At close: Nov 4, 2026, 4:00 PM EST
0.2941
-0.0045 (-1.51%)
After-hours: Nov 4, 2026, 6:55 PM EST

Heron Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
57811512382313163352333025274162551451391802975012865849311,089
Market Cap Growth (YoY)
-68.66%-74.42%-54.99%2.44%-23.47%-40.11%-19.52%-8.79%108.18%279.70%131.23%-14.16%-71.07%-51.43%-69.18%-68.06%-54.00%-81.91%-60.57%-51.60%-19.09%
Enterprise Value
162179246331367442454340413635516358268236253333576333586892997
Last Close Price
0.300.430.801.301.262.072.201.531.993.502.771.701.031.161.512.504.222.795.729.1310.69

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
-------43.05-17.14-------------
Forward PE
-209.09209.09209.09209.09235.23---------------
PS Ratio
0.370.531.001.541.492.112.261.612.193.873.152.011.181.181.582.765.103.016.5110.7812.62
PB Ratio
9.5411.6916.5116.6315.52-11.59-11.78-6.91-7.54-13.90-12.33-7.51-5.22-3.53-15.7621.9022.32-13.1524.3912.009.17
P/TBV Ratio
9.5613.7918.6517.9532.89----------21.9022.32-24.3912.009.17
P/FCF Ratio
-----7.42----31.40---4.23---------
P/OCF Ratio
-----7.65----36.39---4.34---------

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
1.071.181.632.142.372.963.052.363.004.663.902.822.182.002.223.105.863.516.5310.3411.55
EV/EBITDA Ratio
----1478.52---371.20-37.63----3.97---------
EV/EBIT Ratio
----130.49---126.85-29.50----3.85---------
EV/FCF Ratio
-----11.79----42.99---5.93---------

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
21.4821.4815.509.819.44-6.48-6.23-5.28-4.46-4.71-5.31-5.29-6.48-3.97-13.7311.607.04-7.296.642.061.38
Debt / EBITDA Ratio
---61.15--9.848.58---5.27---------
Debt / FCF Ratio
-----4.51----18.54---2.98---------
Net Debt / Equity Ratio
15.3015.3010.606.565.71-4.99-4.45-3.52-2.68-2.93-3.19-2.92-3.69-3.13-8.485.351.62-3.451.970.03-0.32
Net Debt / EBITDA Ratio
-12.10-12.10-11.86-419.6721.4838.28-103.58-13.11-18.85-4.28-1.74-1.10-0.91-0.95-0.71-0.44-0.18-0.35-0.21-0.010.18
Net Debt / FCF Ratio
-8.71-8.71-4.64-3.37-2.73-4.61-5.34-4.89-11.17-4.94-2.41-1.64-1.02-0.96-0.75-0.49-0.23-0.43-0.23-0.010.18
Asset Turnover
0.620.600.550.640.640.640.660.720.600.660.630.610.580.600.500.460.410.430.320.250.25
Inventory Turnover
0.700.620.560.730.860.790.781.081.251.401.231.302.542.761.931.462.843.064.083.443.79
Quick Ratio
1.441.441.421.421.520.471.461.511.611.761.821.761.771.271.431.661.751.131.652.723.40
Current Ratio
2.492.492.532.482.560.822.402.292.282.382.472.372.431.912.292.502.381.772.393.584.36
Return on Equity (ROE)
--273.68%-276.47%-80.88%-----------12232.57%-441.26%-46955.74%-20291.27%-503.41%-222.58%-150.30%
Return on Assets (ROA)
-2.80%-2.05%-4.75%0.04%-4.25%-1.75%3.36%4.60%-5.08%-7.39%-5.45%8.17%-28.96%-50.23%-35.04%-14.30%-40.59%-47.81%-54.30%-39.61%-34.17%
Return on Capital Employed (ROCE)
-6.80%-6.80%-6.70%-1.60%1.00%-4.60%-2.40%-8.10%-6.20%-20.90%-45.40%-65.10%-77.20%-115.50%-97.50%-100.40%-115.90%-160.80%-125.70%-92.20%-78.50%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-61.70%-42.15%-20.51%-8.47%-5.88%-0.29%-2.32%-5.84%-9.27%-9.13%-19.44%-43.34%-82.56%-98.37%-83.80%-61.24%-43.26%-79.50%-39.70%-23.71%-20.96%
FCF Yield
-21.66%-15.02%-13.83%-11.71%-13.48%-9.35%-7.07%-10.41%-3.19%-4.27%-10.74%-23.65%-69.31%-91.90%-71.57%-50.04%-31.21%-60.87%-35.71%-22.18%-19.81%
Buyback Yield / Dilution
-20.47%-23.58%3.69%-22.78%-11.46%-1.13%-30.24%0.03%-5.41%-27.22%-26.80%-31.08%-29.76%-16.91%-16.77%-14.61%-9.64%-4.01%-11.75%-11.96%-12.17%
SEC Filings: 10-K · 10-Q